Skip to main content
Log in

Current Management of Benign Epithelial Gastric Polyps

  • Stomach (DA Johnson, Section Editor)
  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Opinion statement

Purpose of review Benign epithelial gastric polyps, although typically asymptomatic, are identified incidentally on upper endoscopy in up to 23% of patients. These include fundic gland, hyperplastic, and adenomatous polyps. Their appropriate characterization is critical as some have malignant potential, may be indicative of a gastric mucosal field defect, or may be related to an underlying polyposis syndrome. This review will discuss the current management of benign epithelial gastric polyps.

Recent findings Association of gastric polyps with proton pump inhibitor use, Helicobacter pylori infection, risk of malignant transformation, and association with polyposis syndromes have been the focus of recent literature.

Summary All symptomatic polyps, polyps larger than 1 cm in size, and polyps later found to contain dysplasia or cancer should be completely removed. Additionally, random biopsies from the intervening non-polypoid mucosa should be obtained. Finally, identification of multiple polyps of fundic gland type and/or concomitant dysplasia should raise suspicion for an underlying polyposis syndrome and prompt appropriate workup. Surveillance is generally only indicated if there is confirmed dysplasia and/or carcinoma within the polyp itself or if preneoplastic changes are identified in the non-polypoid gastric mucosa.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Marcial MA, Villafana M, Hernandez-Denton J, Colon-Pagan JR. Fundic gland polyps: prevalence and clinicopathologic features. Am J Gastroenterol. 1993;88(10):1711–3.

    CAS  PubMed  Google Scholar 

  2. Archimandritis A, Spiliadis C, Tzivras M, Vamvakousis B, Davaris P, Manika Z, et al. Gastric epithelial polyps: a retrospective endoscopic study of 12974 symptomatic patients. Ital J Gastroenterol. 1996;28(7):387–90.

    CAS  PubMed  Google Scholar 

  3. Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, Wu TT. Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol. 2000;157(3):747–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Weston BR, Helper DJ, Rex DK. Positive predictive value of endoscopic features deemed typical of gastric fundic gland polyps. J Clin Gastroenterol. 2003;36(5):399–402.

    Article  PubMed  Google Scholar 

  5. Jalving M, Koornstra JJ, Wesseling J, Boezen HM, DE Jong S, Kleibeuker JH. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther. 2006;24(9):1341–8.

    Article  CAS  PubMed  Google Scholar 

  6. Carmack SW, Genta RM, Schuler CM, Saboorian MH. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol. 2009;104(6):1524–32.

    Article  PubMed  Google Scholar 

  7. Burt RW. Gastric fundic gland polyps. Gastroenterology. 2003;125(5):1462–9.

    Article  PubMed  Google Scholar 

  8. Voutilainen M, Mantynen T, Kunnamo I, Juhola M, Mecklin JP, Farkkila M. Impact of clinical symptoms and referral volume on endoscopy for detecting peptic ulcer and gastric neoplasms. Scand J Gastroenterol. 2003;38(1):109–13.

    Article  CAS  PubMed  Google Scholar 

  9. Papa A, Cammarota G, Tursi A, Montalto M, Cuoco L, Certo M, et al. Histologic types and surveillance of gastric polyps: a seven year clinico-pathological study. Hepato-Gastroenterology. 1998;45(20):579–82.

    CAS  PubMed  Google Scholar 

  10. Borch K, Skarsgard J, Franzen L, Mardh S, Rehfeld JF. Benign gastric polyps: morphological and functional origin. Dig Dis Sci. 2003;48(7):1292–7.

    Article  CAS  PubMed  Google Scholar 

  11. Ally MR, Veerappan GR, Maydonovitch CL, Duncan TJ, Perry JL, Osgard EM, et al. Chronic proton pump inhibitor therapy associated with increased development of fundic gland polyps. Dig Dis Sci. 2009;54(12):2617–22.

    Article  CAS  PubMed  Google Scholar 

  12. Gencosmanoglu R, Sen-Oran E, Kurtkaya-Yapicier O, Avsar E, Sav A, Tozun N. Gastric polypoid lesions: analysis of 150 endoscopic polypectomy specimens from 91 patients. World J Gastroenterol. 2003;9(10):2236–9.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Goddard AF, Badreldin R, Pritchard DM, Walker MM, Warren B, British Society of G. The management of gastric polyps. Gut. 2010;59(9):1270–6.

    Article  PubMed  Google Scholar 

  14. Ginsberg GG, Al-Kawas FH, Fleischer DE, Reilly HF, Benjamin SB. Gastric polyps: relationship of size and histology to cancer risk. Am J Gastroenterol. 1996;91(4):714–7.

    CAS  PubMed  Google Scholar 

  15. Muehldorfer SM, Stolte M, Martus P, Hahn EG, Ell C, Multicenter Study Group “Gastric Polyps”. Diagnostic accuracy of forceps biopsy versus polypectomy for gastric polyps: a prospective multicentre study. Gut. 2002;50(4):465–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Han AR, Sung CO, Kim KM, Park CK, Min BH, Lee JH, et al. The clinicopathological features of gastric hyperplastic polyps with neoplastic transformations: a suggestion of indication for endoscopic polypectomy. Gut Liv. 2009;3(4):271–5.

    Article  Google Scholar 

  17. Chandrasekhara V, Ginsberg GG. Endoscopic management of gastrointestinal stromal tumors. Curr Gastroenterol Rep. 2011;13(6):532–9.

    Article  PubMed  Google Scholar 

  18. Kinoshita Y, Tojo M, Yano T, Kitajima N, Itoh T, Nishiyama K, et al. Incidence of fundic gland polyps in patients without familial adenomatous polyposis. Gastrointest Endosc. 1993;39(2):161–3.

    Article  CAS  PubMed  Google Scholar 

  19. Stolte M, Sticht T, Eidt S, Ebert D, Finkenzeller G. Frequency, location, and age and sex distribution of various types of gastric polyp. Endoscopy. 1994;26(8):659–65.

    Article  CAS  PubMed  Google Scholar 

  20. Odze RD, Marcial MA, Antonioli D. Gastric fundic gland polyps: a morphological study including mucin histochemistry, stereometry, and MIB-1 immunohistochemistry. Hum Pathol. 1996;27(9):896–903.

    Article  CAS  PubMed  Google Scholar 

  21. Genta RM, Schuler CM, Robiou CI, Lash RH. No association between gastric fundic gland polyps and gastrointestinal neoplasia in a study of over 100,000 patients. Clin Gastroenterol Hepatol. 2009;7(8):849–54.

    Article  PubMed  Google Scholar 

  22. Shaib YH, Rugge M, Graham DY, Genta RM. Management of gastric polyps: an endoscopy-based approach. Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc. 2013;11(11):1374–84.

    Article  Google Scholar 

  23. • Levy MD, Bhattacharya B. Sporadic fundic gland polyps with low-grade dysplasia: a large case series evaluating pathologic and immunohistochemical findings and clinical behavior. Am J Clin Pathol. 2015;144(4):592–600. Studied over 35,000 patients with FGPs and drew a case series of those with dysplasia, with specific attention to morphological and immunohistochemical characteristics in addition to follow-up endoscopic findings

    Article  CAS  PubMed  Google Scholar 

  24. • Nam SY, Park BJ, Ryu KH, Nam JH. Effect of Helicobacter pylori infection and its eradication on the fate of gastric polyps. Euro J Gastroenterol Hepatol. 2016;28(4):449–54. Large cohort study looking at the association of H.pylori infection and its eradication on the identification and fate of gastric polyps

    Google Scholar 

  25. Lloyd IE, Kohlmann WK, Gligorich K, Hall A, Lyon E, Downs-Kelly E, et al. A Clinicopathologic evaluation of incidental fundic gland polyps with dysplasia: implications for clinical management. Am J Gastroenterol. 2017; https://doi.org/10.1038/ajg.2017.125.

  26. Wu TT, Kornacki S, Rashid A, Yardley JH, Hamilton SR. Dysplasia and dysregulation of proliferation in foveolar and surface epithelia of fundic gland polyps from patients with familial adenomatous polyposis. Am J Surg Pathol. 1998;22(3):293–8.

    Article  CAS  PubMed  Google Scholar 

  27. Jalving M, Koornstra JJ, Gotz JM, van der Waaij LA, de Jong S, Zwart N, et al. High-grade dysplasia in sporadic fundic gland polyps: a case report and review of the literature. Euro J Gastroenterol Hepatol. 2003;15(11):1229–33.

    Article  Google Scholar 

  28. Stolte M, Vieth M, Ebert MP. High-grade dysplasia in sporadic fundic gland polyps: clinically relevant or not? Euro J Gastroenterol Hepatol. 2003;15(11):1153–6.

    Article  Google Scholar 

  29. Zelter A, Fernandez JL, Bilder C, Rodriguez P, Wonaga A, Dorado F, et al. Fundic gland polyps and association with proton pump inhibitor intake: a prospective study in 1,780 endoscopies. Dig Dis Sci. 2011;56(6):1743–8.

    Article  CAS  PubMed  Google Scholar 

  30. Zea-Iriarte WL, Sekine I, Itsuno M, Makiyama K, Naito S, Nakayama T, et al. Carcinoma in gastric hyperplastic polyps. A phenotypic study. Dig Dis Sci. 1996;41(2):377–86.

    Article  CAS  PubMed  Google Scholar 

  31. Arnason T, Liang WY, Alfaro E, Kelly P, Chung DC, Odze RD, et al. Morphology and natural history of familial adenomatous polyposis-associated dysplastic fundic gland polyps. Histopathology. 2014;65(3):353–62.

    Article  PubMed  Google Scholar 

  32. Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RK. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet. 1989;2(8666):783–5.

    Article  CAS  PubMed  Google Scholar 

  33. Offerhaus GJ, Giardiello FM, Krush AJ, Booker SV, Tersmette AC, Kelley NC, et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology. 1992;102(6):1980–2.

    Article  CAS  PubMed  Google Scholar 

  34. Odze RD, Quinn PS, Terrault NA, Vivona AA, Ward MA, Cohen Z, et al. Advanced gastroduodenal polyposis with ras mutations in a patient with familial adenomatous polyposis. Hum Pathol. 1993;24(4):442–8.

    Article  CAS  PubMed  Google Scholar 

  35. Zwick A, Munir M, Ryan CK, Gian J, Burt RW, Leppert M, et al. Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli. Gastroenterology. 1997;113(2):659–63.

    Article  CAS  PubMed  Google Scholar 

  36. Wallace MH, Phillips RK. Upper gastrointestinal disease in patients with familial adenomatous polyposis. Br J Surg. 1998;85(6):742–50.

    Article  CAS  PubMed  Google Scholar 

  37. Hofgartner WT, Thorp M, Ramus MW, Delorefice G, Chey WY, Ryan CK, et al. Gastric adenocarcinoma associated with fundic gland polyps in a patient with attenuated familial adenomatous polyposis. Am J Gastroenterol. 1999;94(8):2275–81.

    Article  CAS  PubMed  Google Scholar 

  38. Attard TM, Cuffari C, Tajouri T, Stoner JA, Eisenberg MT, Yardley JH, et al. Multicenter experience with upper gastrointestinal polyps in pediatric patients with familial adenomatous polyposis. Am J Gastroenterol. 2004;99(4):681–6.

    Article  PubMed  Google Scholar 

  39. Sekine S, Shimoda T, Nimura S, Nakanishi Y, Akasu T, Katai H, et al. High-grade dysplasia associated with fundic gland polyposis in a familial adenomatous polyposis patient, with special reference to APC mutation profiles. Mod Pathol. 2004;17(11):1421–6.

    Article  CAS  PubMed  Google Scholar 

  40. Bianchi LK, Burke CA, Bennett AE, Lopez R, Hasson H, Church JM. Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2008;6(2):180–5.

    Article  PubMed  Google Scholar 

  41. Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, Wu TT. Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the beta-catenin gene. Am J Path. 2001;158(3):1005–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Sekine S, Shibata T, Yamauchi Y, Nakanishi Y, Shimoda T, Sakamoto M, et al. Beta-catenin mutations in sporadic fundic gland polyps. Virchows Arch. 2002;440(4):381–6.

    Article  CAS  PubMed  Google Scholar 

  43. Abraham SC, Park SJ, Mugartegui L, Hamilton SR, Wu TT. Sporadic fundic gland polyps with epithelial dysplasia : evidence for preferential targeting for mutations in the adenomatous polyposis coli gene. Am J Path. 2002;161(5):1735–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Aretz S, Uhlhaas S, Goergens H, Siberg K, Vogel M, Pagenstecher C, et al. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer. 2006;119(4):807–14.

    Article  CAS  PubMed  Google Scholar 

  45. Bouguen G, Manfredi S, Blayau M, Dugast C, Buecher B, Bonneau D, et al. Colorectal adenomatous polyposis associated with MYH mutations: genotype and phenotype characteristics. Dis Colon Rectum. 2007;50(10):1612–7.

    Article  PubMed  Google Scholar 

  46. Abraham SC. Fundic gland polyps: common and occasionally problematic lesions. Gastroenterol Hepatol (N Y). 2010;6(1):48–51.

    Google Scholar 

  47. Worthley DL, Phillips KD, Wayte N, Schrader KA, Healey S, Kaurah P, et al. Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome. Gut. 2012;61(5):774–9.

    Article  CAS  PubMed  Google Scholar 

  48. Li J, Woods SL, Healey S, Beesley J, Chen X, Lee JS, et al. Point mutations in exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant. Am J Human Genet. 2016;98(5):830–42.

    Article  CAS  Google Scholar 

  49. Vogt S, Jones N, Christian D, Engel C, Nielsen M, Kaufmann A, et al. Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology. 2009;137(6):1976–85.e1-10.

    Article  CAS  PubMed  Google Scholar 

  50. Graham JR. Gastric polyposis: onset during long-term therapy with omeprazole. Med J Austral. 1992;157(4):287–8.

    CAS  PubMed  Google Scholar 

  51. Graham JR. Omeprazole and gastric polyposis in humans. Gastroenterology. 1993;104(5):1584.

    Article  CAS  PubMed  Google Scholar 

  52. el-Zimaity HM, Jackson FW, Graham DY. Fundic gland polyps developing during omeprazole therapy. Am J Gastroenterol. 1997;92(10):1858–60.

    CAS  PubMed  Google Scholar 

  53. Choudhry U, Boyce HW Jr, Coppola D. Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics. Am J Clin Pathol. 1998;110(5):615–21.

    Article  CAS  PubMed  Google Scholar 

  54. •• Tran-Duy A, Spaetgens B, Hoes AW, de Wit NJ, Stehouwer CD. Use of proton pump inhibitors and risks of fundic gland polyps and gastric cancer: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14(12):1706–19.e5. Major systematic review and meta-analyses on the use of PPIs and their association with an increased likelihood of identification of FGPs on EGD

    Article  CAS  PubMed  Google Scholar 

  55. Ali T, Roberts DN, Tierney WM. Long-term safety concerns with proton pump inhibitors. Am J Med. 2009;122(10):896–903.

    Article  CAS  PubMed  Google Scholar 

  56. Palmer RH. Use of proton pump inhibitors and risks of fundic gland polyps and gastric cancer: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2017;15(5):790.

    Article  PubMed  Google Scholar 

  57. Vieth M, Stolte M. Fundic gland polyps are not induced by proton pump inhibitor therapy. Am J Clin Pathol. 2001;116(5):716–20.

    Article  CAS  PubMed  Google Scholar 

  58. Stolte M. Clinical consequences of the endoscopic diagnosis of gastric polyps. Endoscopy. 1995;27(1):32–7. discussion 59-60

  59. Stolte M. Clinical consequences of the endoscopic diagnosis of gastric polyps. Endoscopy. 1995;27(1):32–7. discussion 59-60

  60. Morais DJ, Yamanaka A, Zeitune JM, Andreollo NA. Gastric polyps: a retrospective analysis of 26,000 digestive endoscopies. Arq Gastroenterol. 2007;44(1):14–7.

    Article  PubMed  Google Scholar 

  61. Al-Haddad M, Ward EM, Bouras EP, Raimondo M. Hyperplastic polyps of the gastric antrum in patients with gastrointestinal blood loss. Dig Dis Sci. 2007;52(1):105–9.

    Article  PubMed  Google Scholar 

  62. Abraham SC, Singh VK, Yardley JH, Wu TT. Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy. Am J Surg Pathol. 2001;25(4):500–7.

    Article  CAS  PubMed  Google Scholar 

  63. Markowski AR, Markowska A, Guzinska-Ustymowicz K. Pathophysiological and clinical aspects of gastric hyperplastic polyps. World J Gastroenterol. 2016;22(40):8883–91.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Ohkusa T, Takashimizu I, Fujiki K, Suzuki S, Shimoi K, Horiuchi T, et al. Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial. Ann Intern Med. 1998;129(9):712–5.

    Article  CAS  PubMed  Google Scholar 

  65. Ljubicic N, Banic M, Kujundzic M, Antic Z, Vrkljan M, Kovacevic I, et al. The effect of eradicating Helicobacter pylori infection on the course of adenomatous and hyperplastic gastric polyps. Euro J Gastroenterol Hepatol. 1999;11(7):727–30.

    Article  CAS  Google Scholar 

  66. Ji F, Wang ZW, Ning JW, Wang QY, Chen JY, Li YM. Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial. World J Wastroenterol. 2006;12(11):1770–3.

    Article  Google Scholar 

  67. Suzuki S, Ohkusa T, Shimoi K, Horiuchi T, Fujiki K, Takashimizu I. Disappearance of multiple hyperplastic polyps after the eradication of Helicobacter pylori. Gastrointest Endosc. 1997;46(6):566–8.

    Article  CAS  PubMed  Google Scholar 

  68. Kume K, Hirakoba M, Murata I, Yoshikawa I, Otsuki M. Disappearance of both MALT lymphoma and hyperplastic polyps in the stomach after eradication of Helicobacter pylori. Am J Gastroenterol. 2001;96(9):2796–7.

    Article  CAS  PubMed  Google Scholar 

  69. Ohkusa T, Miwa H, Hojo M, Kumagai J, Tanizawa T, Asaoka D, et al. Endoscopic, histological and serologic findings of gastric hyperplastic polyps after eradication of Helicobacter pylori: comparison between responder and non-responder cases. Digestion. 2003;68(2–3):57–62.

    Article  PubMed  Google Scholar 

  70. Horvath B, Pai RK. Prevalence of Helicobacter pylori in gastric hyperplastic polyps. Int J Surg Pathol. 2016;24(8):704–8.

    Article  PubMed  Google Scholar 

  71. Kumar A, Quick CR, Carr-Locke DL. Prolapsing gastric polyp, an unusual cause of gastric outlet obstruction: a review of the pathology and management of gastric polyps. Endoscopy. 1996;28(5):452–5.

    Article  CAS  PubMed  Google Scholar 

  72. Ahn JY, Son DH, Choi KD, Roh J, Lim H, Choi KS, et al. Neoplasms arising in large gastric hyperplastic polyps: endoscopic and pathologic features. Gastrointest Endosc. 2014;80(6):1005–13.e2.

    Article  PubMed  Google Scholar 

  73. Omori T, Kamiya Y, Tahara T, Shibata T, Nakamura M, Yonemura J, et al. Correlation between magnifying narrow band imaging and histopathology in gastric protruding/or polypoid lesions: a pilot feasibility trial. BMC Gastroenterol. 2012;12:17.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Varis O, Laxen F, Valle J. Helicobacter pylori infection and fasting serum gastrin levels in a series of endoscopically diagnosed gastric polyps. APMIS. 1994;102(10):759–64.

    Article  CAS  PubMed  Google Scholar 

  75. Park WG, Yan BM, Schellenberg D, Kim J, Chang DT, Koong A, et al. EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy. Gastrointest Endosc. 2010;71(3):513–8.

    Article  PubMed  Google Scholar 

  76. Gonzalez-Obeso E, Fujita H, Deshpande V, Ogawa F, Lisovsky M, Genevay M, et al. Gastric hyperplastic polyps: a heterogeneous clinicopathologic group including a distinct subset best categorized as mucosal prolapse polyp. Am J Surg Pathol. 2011;35(5):670–7.

    Article  PubMed  Google Scholar 

  77. Carmack SW, Genta RM, Graham DY, Lauwers GY. Management of gastric polyps: a pathology-based guide for gastroenterologists. Nat Rev Gastroenterol Hepatol. 2009;6(6):331–41.

    Article  PubMed  Google Scholar 

  78. Orlowska J, Pietrow D. Multifocal gastric carcinoma arising from hyperplastic and adenomatous polyps. Am J Gastroenterol. 1990;85(12):1629–34.

    CAS  PubMed  Google Scholar 

  79. Cristallini EG, Ascani S, Bolis GB. Association between histologic type of polyp and carcinoma in the stomach. Gastrointest Endosc. 1992;38(4):481–4.

    Article  CAS  PubMed  Google Scholar 

  80. Rosen S, Hoak D. Intramucosal carcinoma developing in a hyperplastic gastric polyp. Gastrointest Endosc. 1993;39(6):830–3.

    Article  CAS  PubMed  Google Scholar 

  81. Hizawa K, Fuchigami T, Iida M, Aoyagi K, Iwashita A, Daimaru Y, et al. Possible neoplastic transformation within gastric hyperplastic polyp. Application of endoscopic polypectomy. Surg Endosc. 1995;9(6):714–8.

    Article  CAS  PubMed  Google Scholar 

  82. Orlowska J, Jarosz D, Pachlewski J, Butruk E. Malignant transformation of benign epithelial gastric polyps. Am JGastroenterol. 1995;90(12):2152–9.

    CAS  Google Scholar 

  83. Murakami K, Mitomi H, Yamashita K, Tanabe S, Saigenji K, Okayasu I. p53, but not c-Ki-ras, mutation and down-regulation of p21WAF1/CIP1 and cyclin D1 are associated with malignant transformation in gastric hyperplastic polyps. Am J Clin Pathol. 2001;115(2):224–34.

    Article  CAS  PubMed  Google Scholar 

  84. Dirschmid K, Platz-Baudin C, Stolte M. Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa? Virchows Arch. 2006;448(1):80–4.

    Article  PubMed  Google Scholar 

  85. Park DY, Lauwers GY. Gastric polyps: classification and management. Arch Pathol Lab Med. 2008;132(4):633–40.

    PubMed  Google Scholar 

  86. Jain R, Chetty R. Gastric hyperplastic polyps: a review. Dig Dis Sci. 2009;54(9):1839–46.

    Article  PubMed  Google Scholar 

  87. Dang S, McElreath DP, Kumar S, Kakati B, Atiq M, Morton WJ, et al. Giant gastric hyperplastic polyp: not always a benign lesion. J Ark Med Soc. 2010;107(5):89–92.

    PubMed  Google Scholar 

  88. Kang HM, Oh TH, Seo JY, Joen TJ, Seo DD, Shin WC, et al. Clinical factors predicting for neoplastic transformation of gastric hyperplastic polyps. Kor J Gastroenterol. 2011;58(4):184–9.

    Article  Google Scholar 

  89. Terada T. Malignant transformation of foveolar hyperplastic polyp of the stomach: a histopathological study. Med Oncol. 2011;28(4):941–4.

    Article  PubMed  Google Scholar 

  90. Imura J, Hayashi S, Ichikawa K, Miwa S, Nakajima T, Nomoto K, et al. Malignant transformation of hyperplastic gastric polyps: an immunohistochemical and pathological study of the changes of neoplastic phenotype. Oncol Lett. 2014;7(5):1459–63.

    PubMed  PubMed Central  Google Scholar 

  91. Committee ASoP, Evans JA, Chandrasekhara V, Chathadi KV, Decker GA, Early DS, et al. The role of endoscopy in the management of premalignant and malignant conditions of the stomach. Gastrointest Endosc. 2015;82(1):1–8.

    Article  Google Scholar 

  92. Markowski AR, Guzinska-Ustymowicz K. Gastric hyperplastic polyp with focal cancer. Gastroenterol Rep (Oxf). 2016;4(2):158–61.

    Article  Google Scholar 

  93. Hirota WK, Zuckerman MJ, Adler DG, Davila RE, Egan J, Leighton JA, et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006;63(4):570–80.

    Article  PubMed  Google Scholar 

  94. Committee ASoP, Sharaf RN, Shergill AK, Odze RD, Krinsky ML, Fukami N, et al. Endoscopic mucosal tissue sampling. Gastrointest Endosc. 2013;78(2):216–24.

    Article  Google Scholar 

  95. Cao H, He N, Song S, Xu M, Piao M, Yan F, et al. Is surveillance colonoscopy necessary for patients with sporadic gastric hyperplastic polyps? PLoS One. 2015;10(4):e0122996.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  96. Lewin KJ. Nomenclature problems of gastrointestinal epithelial neoplasia. Am J Surg Pathol. 1998;22(9):1043–7.

    Article  CAS  PubMed  Google Scholar 

  97. Goldstein NS, Lewin KJ. Gastric epithelial dysplasia and adenoma: historical review and histological criteria for grading. Hum Pathol. 1997;28(2):127–33.

    Article  CAS  PubMed  Google Scholar 

  98. Schmitz JM, Stolte M. Gastric polyps as precancerous lesions. Gastrointest Endosc Clin N Am. 1997;7(1):29–46.

    CAS  PubMed  Google Scholar 

  99. Saito K, Arai K, Mori M, Kobayashi R, Ohki I. Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma. Gastrointest Endosc. 2000;52(1):27–32.

    Article  CAS  PubMed  Google Scholar 

  100. Tomasulo J. Gastric polyps. Histologic types and their relationship to gastric carcinoma. Cancer. 1971;27(6):1346–55.

    Article  CAS  PubMed  Google Scholar 

  101. Kamiya T, Morishita T, Asakura H, Miura S, Munakata Y, Tsuchiya M. Long-term follow-up study on gastric adenoma and its relation to gastric protruded carcinoma. Cancer. 1982;50(11):2496–503.

    Article  CAS  PubMed  Google Scholar 

  102. Antonioli DA. Precursors of gastric carcinoma: a critical review with a brief description of early (curable) gastric cancer. Hum Pathol. 1994;25(10):994–1005.

    Article  CAS  PubMed  Google Scholar 

  103. Kolodziejczyk P, Yao T, Oya M, Nakamura S, Utsunomiya T, Ishikawa T, et al. Long-term follow-up study of patients with gastric adenomas with malignant transformation. An immunohistochemical and histochemical analysis. Cancer. 1994;74(11):2896–907.

    Article  CAS  PubMed  Google Scholar 

  104. Rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis. 2008;40(8):650–8.

    Article  CAS  PubMed  Google Scholar 

  105. Rugge M, Correa P, Dixon MF, Hattori T, Leandro G, Lewin K, et al. Gastric dysplasia: the Padova international classification. Am J Surg Pathol. 2000;24(2):167–76.

    Article  CAS  PubMed  Google Scholar 

  106. Rugge M, Nitti D, Farinati F, di Mario F, Genta RM. Non-invasive neoplasia of the stomach. Euro J Gastroenterol Hepatol. 2005;17(11):1191–6.

    Article  Google Scholar 

  107. Kim YJ, Park JC, Kim JH, Shin SK, Lee SK, Lee YC, et al. Histologic diagnosis based on forceps biopsy is not adequate for determining endoscopic treatment of gastric adenomatous lesions. Endoscopy. 2010;42(8):620–6.

    Article  CAS  PubMed  Google Scholar 

  108. Choi CW, Kang DH, Kim HW, Park SB, Kim S, Cho M. Endoscopic submucosal dissection as a treatment for gastric adenomatous polyps: predictive factors for early gastric cancer. Scand J Gastroenterol. 2012;47(10):1218–25.

    Article  PubMed  Google Scholar 

  109. Sakurai U, Lauwers GY, Vieth M, Sawabe M, Arai T, Yoshida T, et al. Gastric high-grade dysplasia can be associated with submucosal invasion: evaluation of its prevalence in a series of 121 endoscopically resected specimens. Am J Surg Pathol. 2014;38(11):1545–50.

    Article  PubMed  Google Scholar 

  110. Facciorusso A, Antonino M, Di Maso M, Muscatiello N. Endoscopic submucosal dissection vs endoscopic mucosal resection for early gastric cancer: a meta-analysis. World J Gastrointest Endosc. 2014;6(11):555–63.

    Article  PubMed  PubMed Central  Google Scholar 

  111. Yoon SB, Park JM, Lim CH, Kim JS, Cho YK, Lee BI, et al. Incidence of gastric cancer after endoscopic resection of gastric adenoma. Gastrointest Endosc. 2016;83(6):1176–83.

    Article  PubMed  Google Scholar 

  112. Kim SY, Sung JK, Moon HS, Kim KS, Jung IS, Yoon BY, et al. Is endoscopic mucosal resection a sufficient treatment for low-grade gastric epithelial dysplasia? Gut Liver. 2012;6(4):446–51.

    Article  PubMed  PubMed Central  Google Scholar 

  113. Oh CM, Won YJ, Jung KW, Kong HJ, Cho H, Lee JK, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat. 2016;48(2):436–50.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Min Cui, MD, PhD

Department of Pathology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY.

Author information

Authors and Affiliations

Authors

Contributions

Antonio R. Cheesman: manuscript writing, edition, and revisions.

David A. Greenwald: manuscript edition and revisions.

Shailja C. Shah: manuscript writing, edition and revisions, article guarantor.

Corresponding author

Correspondence to Shailja C. Shah MD.

Ethics declarations

Conflict of Interest

Antonio R. Cheesman declares that he has no conflict of interest. David A. Greenwald declares that he has no conflict of interest. Shailja C. Shah declares that she has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Stomach

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cheesman, A.R., Greenwald, D.A. & Shah, S.C. Current Management of Benign Epithelial Gastric Polyps. Curr Treat Options Gastro 15, 676–690 (2017). https://doi.org/10.1007/s11938-017-0159-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-017-0159-6

Keywords

Navigation